Online Testosterone Prescription. 2026 Comparison
Compare verified online testosterone prescription offers and published billing terms. Review the exact medication and commitment before enrolling.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Online TRT now covers the full delivery-route spectrum: injectable cypionate or enanthate (the gold-standard for serum trough control), transdermal cream or gel, subcutaneous pellets, sublingual troche, and oral options like KYZATREX or Jatenzo. The choice between routes is the single biggest decision in TRT and affects everything from labs to costs to what your insurance covers. Below: route comparison, lab requirements, the enclomiphene alternative for men who want fertility preservation, and how the major TRT-focused telehealth platforms differ.
Testosterone replacement therapy (TRT) is the prescription of exogenous testosterone for men with clinically confirmed hypogonadism (total T <300 ng/dL on at least two morning draws, with supportive symptoms). Per the 2018 Endocrine Society and 2024 AUA guidelines, TRT is appropriate only for documented hypogonadism, not for low-normal testosterone in symptomatic men, and not as a performance-enhancement protocol.
Men with documented hypogonadism (total testosterone <300 ng/dL on two morning draws, plus supportive symptoms: low libido, erectile dysfunction, fatigue, decreased muscle mass, mood changes). Best fit for men over 40 with primary or secondary hypogonadism. Not appropriate for men trying to conceive (suppresses spermatogenesis. Use enclomiphene instead). Caution in men with prostate cancer history, severe sleep apnea, polycythemia, or severe heart failure. Not appropriate as a recreational or performance-enhancement protocol.
Most providers require pre-treatment labs: total + free testosterone (two morning draws), CBC, CMP, lipid panel, HbA1c, PSA (men 40+), and prolactin. Follow-up labs at 8–12 weeks to confirm therapeutic levels (target 500–800 ng/dL) and screen for hematocrit elevation. Injectable testosterone cypionate (the most common): $30–$50/mo for the medication, $100–$200/mo all-in including consult and labs. Cream/gel: $80–$150/mo. Pellets: $400–$800 per insertion every 3–6 months. Oral KYZATREX/Jatenzo: $500–$700/mo. Most platforms require quarterly check-ins and annual labs as standard of care.
Verified Offers for online
Hone Health
Hormone optimisation platform with real biomarker testing and physician-guided protocols, for men and women.
MangoRx
Custom-compounded, rapid-dissolve treatments for men's health with transparent pricing and free provider visits.
Online doctor's office and pharmacy with 48-hour delivery and no required virtual visit in most states.
What the Studies Actually Show
Testosterone replacement therapy is FDA-approved for documented hypogonadism. The figures below come from the Endocrine Society and AUA clinical practice guidelines and from the FDA prescribing information.
| Endpoint | Finding |
|---|---|
| Diagnostic threshold (Endocrine Society 2018)1 | Treatment is considered when total testosterone is consistently below ~264 ng/dL with consistent symptoms of hypogonadism |
| Cardiovascular safety (TRAVERSE, 5,246 men, ~33 months)2 | Testosterone replacement was non-inferior to placebo for major adverse cardiovascular events in middle-aged and older men with hypogonadism and elevated CV risk |
| Required safety monitoring (AUA 2018)3 | Hematocrit at baseline, 3–6 months, then annually; PSA at baseline and at follow-up testing in men age ≥40; lipids and CMP at baseline and 6–12 months |
| Hematocrit safety endpoint3 | Treatment paused if hematocrit exceeds 54% to reduce thrombotic risk |
| Fertility1 | Exogenous testosterone suppresses LH/FSH and spermatogenesis. Men interested in fertility should consider enclomiphene or hCG instead, or alongside, TRT |
Frequently Asked Questions
What is the cheapest legitimate TRT option in 2026?
Injectable testosterone cypionate via telehealth runs $30–$50/mo for the medication itself, with all-in costs (consult fees + labs + medication + needles/syringes) typically $100–$200/mo at platforms like Hone Health, Peter MD, and FuturHealth. Self-administered weekly subcutaneous injection is the standard protocol. Cream/gel is more convenient but 2–3x more expensive. Oral testosterone (KYZATREX, Jatenzo) is the most expensive route.
Will TRT make me infertile?
Yes, exogenous testosterone suppresses LH and FSH, which suppresses spermatogenesis. After 3–6 months on TRT, most men have severely reduced or absent sperm production. This is reversible in most men after 6–18 months off TRT, but recovery is not guaranteed and varies with age and duration of therapy. Men who want to preserve fertility should consider enclomiphene instead, or add hCG to TRT to maintain testicular function. Discuss family planning with your TRT provider before starting.
Enclomiphene vs TRT, which should I choose?
Enclomiphene (off-label for hypogonadism) raises endogenous testosterone by stimulating LH/FSH, it preserves fertility and avoids the testicular atrophy associated with TRT. Best fit for younger men (under 50), men with secondary hypogonadism, and men who want to preserve fertility. TRT delivers more reliable serum levels and faster symptom relief but suppresses fertility. We have a dedicated enclomiphene vs TRT comparison resource.
Which telehealth providers are best for TRT?
Hone Health and Peter MD lead on clinical structure (full lab panels, regular follow-up). FuturHealth and BB Health+ offer coaching-bundled TRT for patients who want lifestyle support alongside hormones. Henry Meds is the price-leader for straightforward injectable TRT. SkinnyRx and BraverX cover TRT as part of broader men's health platforms. Avoid platforms that prescribe TRT without pre-treatment labs or that offer 'TRT' for low-normal testosterone in young men. These are high-risk red flags.
What labs are required before starting TRT?
Per the Endocrine Society guidelines: total testosterone (two morning draws to confirm <300 ng/dL), free or bioavailable testosterone, LH, FSH, prolactin (rule out prolactinoma), CBC (baseline hematocrit), CMP (kidney/liver), lipid panel, HbA1c, and PSA in men 40+. Reputable telehealth platforms require all of these before prescribing. Platforms that prescribe TRT after a single morning T draw or without prolactin/PSA are operating below standard of care.
Does insurance cover TRT?
Most commercial insurance plans cover TRT for documented hypogonadism with prior authorization, usually requiring two morning T draws below 300 ng/dL. Coverage typically applies to injectable testosterone cypionate or enanthate; cream/gel coverage varies; oral testosterone is rarely covered first-line. Medicare Part D covers injectable testosterone for hypogonadism. Most TRT-focused telehealth platforms operate on a cash-pay model because the insurance navigation and prior-auth process is more expensive than the medication itself.
What side effects should I monitor on TRT?
Most common: erythrocytosis (elevated hematocrit: monitor every 3–6 months, may require dose reduction or therapeutic phlebotomy if HCT >54%), acne, mood changes, sleep apnea worsening, and fluid retention. Estrogen-related effects (gynecomastia, water retention) are common at supraphysiologic doses. Long-term concerns: prostate growth (PSA monitoring required), cardiovascular risk (TRAVERSE trial 2023 showed no excess MACE risk with replacement-dose TRT). Spermatogenesis suppression is universal but often reversible. Liver toxicity is specific to oral TRT (KYZATREX, Jatenzo).
- Endocrine Society Guideline — J Clin Endocrinol Metab 2018 · Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018;103(5):1715–1744.
- TRAVERSE — NEJM 2023 · Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med 2023;389:107–117.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.